Sasaki, Lena
Hamada, Yuki
Yarimizu, Daisuke
Suzuki, Tomo
Nakamura, Hiroki
Shimada, Aya
Pham, Khanh Tien Nguyen
Shao, Xinyan
Yamamura, Koki
Inatomi, Tsutomu
Morinaga, Hironobu
Nishimura, Emi K. http://orcid.org/0000-0002-5767-8045
Kudo, Fujimi
Manabe, Ichiro http://orcid.org/0000-0001-9481-6673
Haraguchi, Shogo http://orcid.org/0000-0002-8731-3311
Sugiura, Yuki
Suematsu, Makoto http://orcid.org/0000-0002-7165-6336
Kinoshita, Shigeru
Machida, Mamiko
Nakajima, Takeshi
Kiyonari, Hiroshi http://orcid.org/0000-0002-1509-8747
Okamura, Hitoshi
Yamaguchi, Yoshiaki
Miyake, Takahito http://orcid.org/0000-0002-4356-5883
Doi, Masao http://orcid.org/0000-0001-6264-9217
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21gm5010002)
Ministry of Education, Culture, Sports, Science and Technology (18H04015, 20B307)
Article History
Received: 3 April 2021
Accepted: 22 December 2021
First Online: 10 February 2022
Competing interests
: M.D., T.N. and M.M. have filed a patent application related to the new uses of NMN and NR (WO2020262497). M.D., T.S. and S.K. received institutional research funding from Senju Pharmaceutical Co. T.N. and M.M. are employees of Senju Pharmaceutical Co. All other authors declare no competing interests.